Syngene International Q2 Results
- BSE: 539268
- NSE: SYNGENE
- ISIN: INE398R01022
- Sector: Biotechnology & Drugs
BSE
434.50
-1.00 (-0.23%)
-1.00 (-0.23%)Volume13.53 K
Updated: Fri 5 Jun, 2026 | 15:29:51
NSE
434-1.55 (-0.36%)
-1.55 (-0.36%)Volume2.89 L
Updated: Fri 5 Jun, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Syngene International Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 815.80 | 774.50 | 5.33% | 761.40 | 7.14% |
| Depreciation/ Amortization | 116.50 | 111.20 | 4.77% | 110.90 | 5.05% |
| Operating Income | 94.80 | 100.00 | -5.20% | 129.60 | -26.85% |
| Net Income | 67.10 | 86.70 | -22.61% | 106.10 | -36.76% |
| Other Operating Expenses Total | 185.80 | 184.00 | 0.98% | 162.40 | 14.41% |
| Net Income Before Taxes | 85.20 | 101.30 | -15.89% | 137.30 | -37.95% |
| Total Revenue | 910.60 | 874.50 | 4.13% | 891.00 | 2.20% |
| Selling/ General/ Admin Expenses Total | 275.00 | 261.70 | 5.08% | 251.50 | 9.34% |
| Diluted Normalized EPS | 1.67 | 2.15 | -22.33% | 2.64 | -36.74% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.